Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?

Muhammad Abdul-Ghani

Research output: Contribution to journal › Comment/debate › peer-review

43 Scopus citations

Fingerprint

Dive into the research topics of 'Where does combination therapy with an SGLT2 inhibitor plus a DPP-4 Inhibitor fit in the management of type 2 diabetes?'. Together they form a unique fingerprint.